🇺🇸 FDA
Pipeline program

Testosterone enanthate

ATRS QST-19-007

Phase 3 other active

Quick answer

Testosterone enanthate for Hypogonadism, Male is a Phase 3 program (other) at HALOZYME THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
HALOZYME THERAPEUTICS, INC.
Indication
Hypogonadism, Male
Phase
Phase 3
Modality
other
Status
active

Clinical trials